Symbols / CCM Stock $5.06 -5.42% Concord Medical Services Holdings Limited

Healthcare • Medical Care Facilities • China • NYQ
CCM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Dr. Jianyu Yang
Exch · Country NYQ · China
Market Cap 21.97M
Enterprise Value 7.93B
Income -92.81M
Sales 460.51M
FCF (ttm) -313.65M
Book/sh -71.33
Cash/sh 2.29
Employees —
Insider 10d —
IPO Dec 11, 2009
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -33.73
PEG 0.56
P/S 0.05
P/B -0.07
P/C —
EV/EBITDA -79.53
EV/Sales 17.22
Quick Ratio 0.17
Current Ratio 0.48
Debt/Eq 195.39
LT Debt/Eq —
EPS (ttm) -3.14
EPS next Y -0.15
EPS Growth —
Revenue Growth 57.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2020-04-29
Earnings (prior) 2020-04-29
ROA -2.25%
ROE -21.88%
ROIC —
Gross Margin 5.61%
Oper. Margin -36.43%
Profit Margin -20.15%
Shs Outstand 2.82M
Shs Float 41.94M
Insider Own 18.00%
Instit Own 0.03%
Short Float 0.23%
Short Ratio 1.93
Short Interest 3.19K
52W High 10.77
vs 52W High -53.02%
52W Low 3.18
vs 52W Low 59.12%
Beta —
Impl. Vol. —
Rel Volume 7.04
Avg Volume 16.67K
Volume 117.41K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $5.35
Price $5.06
Change -5.42%
About

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$5.06
Latest analyst target
3. DCF / Fair value
$-2005.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.06
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2012-11-23 main Morgan Stanley — → Overweight $6
2012-07-06 main Morgan Stanley — → Overweight $4
2012-03-22 main JP Morgan — → Overweight $5
News
RSS: Latest CCM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
460.51
+19.94%
383.96
-28.55%
537.40
+13.84%
472.08
Operating Revenue
460.51
+19.94%
383.96
-28.55%
537.40
+13.84%
472.08
Cost Of Revenue
434.69
-6.14%
463.12
-24.57%
614.01
-1.68%
624.49
Reconciled Cost Of Revenue
434.69
-6.14%
463.12
-24.57%
614.01
-1.68%
624.49
Gross Profit
25.82
+132.62%
-79.16
-3.33%
-76.61
+49.74%
-152.41
Operating Expense
265.15
-41.47%
453.00
+17.24%
386.38
+3.69%
372.64
Selling General And Administration
265.15
-41.47%
453.00
+17.24%
386.38
+3.69%
372.64
Selling And Marketing Expense
52.18
+7.32%
48.63
-13.63%
56.30
-8.43%
61.48
General And Administrative Expense
212.97
-47.33%
404.37
+22.51%
330.08
+6.08%
311.16
Other Gand A
212.97
-47.33%
404.37
+22.51%
330.08
+6.08%
311.16
Total Expenses
699.85
-23.61%
916.12
-8.42%
1,000.39
+0.33%
997.13
Operating Income
-239.33
+55.03%
-532.16
-14.94%
-462.99
+11.82%
-525.05
Total Operating Income As Reported
-261.49
+50.86%
-532.16
-14.94%
-462.99
+11.82%
-525.05
EBITDA
-71.77
+79.23%
-345.62
-32.18%
-261.47
+55.44%
-586.73
Normalized EBITDA
-75.05
+80.46%
-383.99
-22.41%
-313.69
+46.03%
-581.18
Reconciled Depreciation
149.26
+14.15%
130.76
+1.79%
128.45
-3.28%
132.81
EBIT
-221.03
+53.60%
-476.38
-22.17%
-389.93
+45.81%
-719.54
Total Unusual Items
3.27
-91.47%
38.37
-26.53%
52.22
+1041.00%
-5.55
Total Unusual Items Excluding Goodwill
3.27
-91.47%
38.37
-26.53%
52.22
+1041.00%
-5.55
Special Income Charges
15.31
-68.35%
48.38
+31.25%
36.86
+159.89%
-61.55
Impairment Of Capital Assets
22.16
0.00
0.00
0.00
Net Income
-92.81
+69.89%
-308.24
-3.56%
-297.66
+39.21%
-489.66
Pretax Income
-373.36
+44.24%
-669.58
-20.52%
-555.59
+33.85%
-839.90
Net Non Operating Interest Income Expense
-142.64
+20.41%
-179.22
-15.75%
-154.84
-40.33%
-110.34
Interest Expense Non Operating
152.33
-21.16%
193.20
+16.62%
165.67
+37.65%
120.36
Net Interest Income
-142.64
+20.41%
-179.22
-15.75%
-154.84
-40.33%
-110.34
Interest Expense
152.33
-21.16%
193.20
+16.62%
165.67
+37.65%
120.36
Interest Income Non Operating
9.68
-30.74%
13.98
+29.08%
10.83
+8.09%
10.02
Interest Income
9.68
-30.74%
13.98
+29.08%
10.83
+8.09%
10.02
Other Income Expense
8.62
-79.38%
41.80
-32.83%
62.23
+130.43%
-204.51
Other Non Operating Income Expenses
-7.70
+16.87%
-9.26
+14.04%
-10.78
+95.02%
-216.61
Gain On Sale Of Security
-12.04
-20.25%
-10.01
-165.20%
15.36
-72.58%
56.00
Gain On Sale Of Business
37.47
-22.54%
48.38
+31.25%
36.86
+159.89%
-61.55
Tax Provision
6.06
+134.64%
-17.50
+28.76%
-24.57
+65.34%
-70.91
Tax Rate For Calcs
0.00
+856.28%
0.00
-40.89%
0.00
-47.61%
0.00
Tax Effect Of Unusual Items
0.82
-18.44%
1.00
-56.57%
2.31
+592.98%
-0.47
Net Income Including Noncontrolling Interests
-379.42
+41.81%
-652.08
-22.80%
-531.02
+30.95%
-768.99
Net Income From Continuing Operation Net Minority Interest
-92.81
+69.89%
-308.24
-3.56%
-297.66
+39.21%
-489.66
Net Income From Continuing And Discontinued Operation
-92.81
+69.89%
-308.24
-3.56%
-297.66
+39.21%
-489.66
Net Income Continuous Operations
-379.42
+41.81%
-652.08
-22.80%
-531.02
+30.95%
-768.99
Minority Interests
286.61
-16.64%
343.83
+47.34%
233.36
-16.46%
279.33
Normalized Income
-95.27
+72.44%
-345.61
+0.56%
-347.56
+28.28%
-484.58
Net Income Common Stockholders
-92.81
+69.89%
-308.24
-3.56%
-297.66
+39.21%
-489.66
Otherunder Preferred Stock Dividend
0.00
0.00
0.00
0.00
Diluted EPS
—
-70.50
-3.52%
-68.10
+39.30%
-112.20
Basic EPS
—
-70.50
-3.52%
-68.10
+39.30%
-112.20
Basic Average Shares
—
4.37
+0.00%
4.37
+0.00%
4.37
Diluted Average Shares
—
4.37
+0.00%
4.37
+0.00%
4.37
Diluted NI Availto Com Stockholders
-92.81
+69.89%
-308.24
-3.56%
-297.66
+39.21%
-489.66
Earnings From Equity Interest
13.05
+2.76%
12.70
-38.93%
20.79
+17.80%
17.65
Gain On Sale Of PPE
—
—
0.06
+2166.67%
-0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,547.36
-2.66%
6,726.39
+11.11%
6,053.94
+0.82%
6,004.93
Current Assets
941.91
-4.27%
983.97
+59.42%
617.21
-18.77%
759.80
Cash Cash Equivalents And Short Term Investments
297.79
-15.12%
350.85
+503.46%
58.14
-63.27%
158.28
Cash And Cash Equivalents
297.79
+37.72%
216.22
+271.91%
58.14
-63.27%
158.28
Other Short Term Investments
0.00
-100.00%
134.62
0.00
—
Receivables
44.05
-13.91%
51.17
-30.38%
73.50
-43.58%
130.27
Accounts Receivable
44.05
-13.91%
51.17
-30.38%
73.50
-43.58%
130.27
Gross Accounts Receivable
90.20
-4.09%
94.05
-9.55%
103.98
-24.67%
138.03
Allowance For Doubtful Accounts Receivable
-46.16
-7.63%
-42.88
-40.67%
-30.49
-292.66%
-7.76
Receivables Adjustments Allowances
—
—
—
-17.29
Other Receivables
—
—
—
61.21
Taxes Receivable
—
—
—
44.50
Accrued Interest Receivable
—
—
—
—
Loans Receivable
—
—
—
294.13
Inventory
45.97
+37.45%
33.44
-17.12%
40.35
-52.44%
84.83
Raw Materials
39.18
+25.20%
31.29
-15.17%
36.89
-51.17%
75.55
Finished Goods
7.33
+167.45%
2.74
-32.11%
4.04
-59.22%
9.90
Prepaid Assets
—
—
—
2.60
Current Deferred Assets
—
—
—
0.20
Restricted Cash
0.92
-95.56%
20.76
-35.69%
32.28
+2945.28%
1.06
Other Current Assets
553.19
+4.82%
527.76
+27.80%
412.95
+7.16%
385.35
Total Non Current Assets
5,605.45
-2.39%
5,742.42
+5.62%
5,436.73
+3.65%
5,245.13
Net PPE
3,972.04
-0.99%
4,011.79
+7.44%
3,734.03
+8.06%
3,455.49
Gross PPE
4,470.51
+1.28%
4,413.85
+6.92%
4,128.08
+9.21%
3,779.85
Accumulated Depreciation
-498.47
-23.98%
-402.06
-2.03%
-394.05
-21.49%
-324.36
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
823.24
+3.15%
798.10
-1.19%
807.74
+3.22%
782.56
Machinery Furniture Equipment
51.88
-10.32%
57.85
-7.76%
62.72
+1.56%
61.76
Construction In Progress
2,521.86
+1.60%
2,482.22
+0.46%
2,470.97
+15.42%
2,140.92
Other Properties
995.62
-0.24%
998.00
+41.58%
704.89
-2.04%
719.58
Leases
77.89
+0.27%
77.68
-4.99%
81.77
+8.97%
75.03
Goodwill And Other Intangible Assets
1,206.73
-3.66%
1,252.59
-3.39%
1,296.57
-3.00%
1,336.68
Goodwill
572.22
+0.00%
572.22
-0.56%
575.43
+0.00%
575.43
Other Intangible Assets
634.51
-6.74%
680.37
-5.65%
721.15
-5.27%
761.25
Investments And Advances
422.00
-10.62%
472.17
+19.62%
394.71
-9.86%
437.87
Long Term Equity Investment
422.00
-10.62%
472.17
+19.62%
394.71
+1.79%
387.78
Non Current Accounts Receivable
—
—
—
—
Non Current Prepaid Assets
1.38
-48.58%
2.68
-47.26%
5.08
-29.87%
7.25
Other Non Current Assets
3.30
+3.64%
3.19
-49.77%
6.34
-19.14%
7.84
Total Liabilities Net Minority Interest
4,697.25
-8.05%
5,108.64
+18.61%
4,306.96
+7.96%
3,989.28
Current Liabilities
1,954.41
-8.04%
2,125.36
+8.91%
1,951.39
+74.04%
1,121.24
Payables And Accrued Expenses
835.72
-16.52%
1,001.06
+24.64%
803.14
+72.11%
466.64
Payables
374.51
-17.41%
453.43
+8.97%
416.10
+6.25%
391.63
Accounts Payable
119.29
-40.17%
199.39
+54.29%
129.24
-11.93%
146.75
Other Payable
217.38
-1.06%
219.71
-18.54%
269.73
+24.81%
216.11
Current Accrued Expenses
461.21
-15.78%
547.63
+41.49%
387.04
+415.98%
75.01
Total Tax Payable
37.85
+10.24%
34.33
+100.29%
17.14
-40.44%
28.78
Income Tax Payable
7.57
+366.36%
1.62
+6.64%
1.52
+86.06%
0.82
Current Debt And Capital Lease Obligation
1,022.99
-5.12%
1,078.14
-0.97%
1,088.68
+98.48%
548.50
Current Debt
981.06
-5.00%
1,032.70
-0.91%
1,042.19
+103.32%
512.58
Other Current Borrowings
671.10
+34.57%
498.71
-31.72%
730.37
+104.54%
357.09
Current Capital Lease Obligation
41.92
-7.75%
45.45
-2.25%
46.49
+29.45%
35.92
Current Deferred Liabilities
95.70
+107.36%
46.15
-22.32%
59.41
-41.06%
100.80
Current Deferred Revenue
95.70
+107.36%
46.15
-22.32%
59.41
-41.06%
100.80
Other Current Liabilities
—
—
0.16
-96.92%
5.29
Total Non Current Liabilities Net Minority Interest
2,742.84
-8.06%
2,983.28
+26.65%
2,355.56
-17.87%
2,868.04
Long Term Debt And Capital Lease Obligation
2,612.00
-8.43%
2,852.59
+29.25%
2,207.02
-18.00%
2,691.38
Long Term Debt
2,485.51
-8.41%
2,713.69
+34.74%
2,014.01
-19.16%
2,491.43
Long Term Capital Lease Obligation
126.50
-8.92%
138.89
-28.04%
193.01
-3.47%
199.95
Non Current Deferred Liabilities
75.00
-9.49%
82.87
-16.75%
99.54
-11.58%
112.58
Non Current Deferred Taxes Liabilities
75.00
-9.49%
82.87
-16.75%
99.54
-11.58%
112.58
Other Non Current Liabilities
4.13
+24.41%
3.32
-26.69%
4.53
+19.76%
3.79
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
-2,103.11
+7.77%
-2,280.39
-7.47%
-2,121.95
-13.84%
-1,863.97
Common Stock Equity
-2,103.11
+7.77%
-2,280.39
-7.47%
-2,121.95
-13.84%
-1,863.97
Capital Stock
0.10
+0.00%
0.10
+0.00%
0.10
+0.00%
0.10
Common Stock
0.10
+0.00%
0.10
+0.00%
0.10
+0.00%
0.10
Share Issued
142.35
+0.00%
142.35
+0.00%
142.35
+0.00%
142.35
Ordinary Shares Number
130.25
+0.00%
130.25
+0.00%
130.25
+0.00%
130.25
Treasury Shares Number
12.10
+0.00%
12.10
+0.00%
12.10
+0.00%
12.10
Additional Paid In Capital
2,438.00
+12.37%
2,169.69
+8.05%
2,007.96
+4.01%
1,930.63
Retained Earnings
-4,465.64
-2.12%
-4,372.83
-7.58%
-4,064.59
-7.90%
-3,766.93
Gains Losses Not Affecting Retained Earnings
-75.56
+2.31%
-77.35
-18.24%
-65.42
-135.61%
-27.77
Treasury Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Minority Interest
3,953.23
+1.41%
3,898.14
+0.75%
3,868.93
-0.28%
3,879.62
Other Equity Adjustments
-75.56
+2.31%
-77.35
-18.24%
-65.42
-135.61%
-27.77
Total Equity Gross Minority Interest
1,850.12
+14.36%
1,617.75
-7.40%
1,746.99
-13.33%
2,015.66
Total Capitalization
382.39
-11.75%
433.30
+501.46%
-107.93
-117.20%
627.46
Working Capital
-1,012.50
+11.29%
-1,141.38
+14.45%
-1,334.19
-269.13%
-361.44
Invested Capital
1,363.46
-6.99%
1,466.00
+56.92%
934.26
-18.05%
1,140.04
Total Debt
3,634.99
-7.52%
3,930.73
+19.27%
3,295.70
+1.72%
3,239.88
Net Debt
3,168.78
-10.24%
3,530.16
+17.75%
2,998.06
+5.35%
2,845.73
Capital Lease Obligations
168.42
-8.64%
184.34
-23.03%
239.50
+1.54%
235.87
Net Tangible Assets
-3,309.84
+6.32%
-3,532.98
-3.35%
-3,418.52
-6.81%
-3,200.64
Tangible Book Value
-3,309.84
+6.32%
-3,532.98
-3.35%
-3,418.52
-6.81%
-3,200.64
Available For Sale Securities
—
—
18.92
-62.22%
50.10
Derivative Product Liabilities
—
—
—
0.00
Inventories Adjustments Allowances
-0.54
+8.63%
-0.59
-2.78%
-0.57
+5.27%
-0.61
Investmentin Financial Assets
—
—
18.92
-62.22%
50.10
Line Of Credit
309.97
-41.95%
533.99
+71.25%
311.81
+100.53%
155.50
Non Current Accrued Expenses
51.70
+16.16%
44.50
+0.08%
44.47
-26.25%
60.30
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-201.82
+49.26%
-397.75
-43.87%
-276.47
-27.59%
-216.69
Cash Flow From Continuing Operating Activities
-201.82
+49.26%
-397.75
-43.87%
-276.47
-27.59%
-216.69
Net Income From Continuing Operations
-379.42
+41.81%
-652.08
-22.80%
-531.02
+30.95%
-768.99
Depreciation Amortization Depletion
149.26
+14.15%
130.76
+1.79%
128.45
-3.28%
132.81
Depreciation
103.51
+22.10%
84.78
+3.23%
82.12
-7.41%
88.69
Amortization Cash Flow
45.75
-0.51%
45.98
-0.75%
46.33
+5.00%
44.12
Depreciation And Amortization
149.26
+14.15%
130.76
+1.79%
128.45
-3.28%
132.81
Amortization Of Intangibles
45.75
-0.51%
45.98
-0.75%
46.33
+5.00%
44.12
Other Non Cash Items
167.14
-22.54%
215.78
+12.18%
192.35
-44.07%
343.93
Stock Based Compensation
0.00
0.00
0.00
+100.00%
-5.92
Provisionand Write Offof Assets
-6.83
-105.33%
128.20
+98.10%
64.71
+1098.37%
5.40
Asset Impairment Charge
22.16
0.00
0.00
0.00
Deferred Tax
-7.87
+49.73%
-15.65
-20.04%
-13.04
+81.85%
-71.85
Deferred Income Tax
-7.87
+49.73%
-15.65
-20.04%
-13.04
+81.85%
-71.85
Operating Gains Losses
-48.42
-0.61%
-48.13
+23.51%
-62.92
-246.71%
42.89
Gain Loss On Investment Securities
—
-0.17
+96.81%
-5.21
-413.00%
-1.01
Unrealized Gain Loss On Investment Securities
0.00
+100.00%
-7.29
0.00
0.00
Gain Loss On Sale Of PPE
2.10
-84.00%
13.11
+21245.16%
-0.06
-2166.67%
0.00
Change In Working Capital
-97.84
+34.48%
-149.33
-171.46%
-55.01
-152.37%
105.03
Change In Receivables
6.14
-48.87%
12.02
-67.03%
36.45
+5560.56%
0.64
Changes In Account Receivables
6.14
-48.87%
12.02
-67.03%
36.45
+5560.56%
0.64
Change In Inventory
-12.58
-293.54%
6.50
-85.39%
44.49
+195.16%
-46.75
Change In Prepaid Assets
161.28
+148.05%
-335.66
-124.16%
-149.74
-15.05%
-130.16
Change In Payables And Accrued Expense
-275.35
-244.40%
190.69
+166.72%
71.49
-68.52%
227.08
Change In Accrued Expense
-159.00
-263.03%
97.53
+77.31%
55.01
-51.11%
112.52
Change In Payable
-116.34
-224.89%
93.15
+465.11%
16.48
-85.61%
114.56
Change In Account Payable
-122.29
-231.42%
93.05
+489.72%
15.78
-86.13%
113.74
Change In Other Working Capital
39.53
+1379.83%
-3.09
+92.50%
-41.18
-172.03%
57.17
Change In Other Current Assets
-0.96
-109.17%
-0.46
-128.31%
1.62
+10886.67%
-0.01
Change In Other Current Liabilities
-15.92
+17.65%
-19.33
-6.52%
-18.15
-518.30%
-2.94
Investing Cash Flow
53.97
+109.09%
-593.44
-1144.61%
-47.68
+59.86%
-118.79
Cash Flow From Continuing Investing Activities
53.97
+109.09%
-593.44
-1144.61%
-47.68
+59.86%
-118.79
Net PPE Purchase And Sale
-83.80
+79.08%
-400.67
-247.23%
-115.39
+69.48%
-378.14
Purchase Of PPE
-91.30
+77.21%
-400.67
-246.30%
-115.70
+69.85%
-383.77
Sale Of PPE
7.50
0.00
-100.00%
0.31
-94.50%
5.63
Capital Expenditure
-91.33
+77.77%
-410.83
-242.61%
-119.91
+68.84%
-384.81
Net Investment Purchase And Sale
134.62
+235.07%
-99.67
0.00
-100.00%
11.95
Purchase Of Investment
—
-204.61
0.00
0.00
Sale Of Investment
134.62
+28.28%
104.94
0.00
-100.00%
11.95
Net Business Purchase And Sale
-0.01
+99.99%
-92.94
-255.16%
59.90
+2704.35%
-2.30
Purchase Of Business
-0.01
+99.99%
-102.00
-101900.00%
-0.10
+95.65%
-2.30
Gain Loss On Sale Of Business
0.00
+100.00%
-48.50
-7701.41%
0.64
-98.96%
61.55
Net Intangibles Purchase And Sale
-0.03
+99.70%
-10.16
-141.27%
-4.21
-307.65%
-1.03
Purchase Of Intangibles
-0.03
+99.70%
-10.16
-141.27%
-4.21
-307.65%
-1.03
Net Other Investing Changes
—
—
—
245.63
Financing Cash Flow
197.23
-82.79%
1,146.03
+344.80%
257.65
-32.74%
383.09
Cash Flow From Continuing Financing Activities
197.23
-82.79%
1,146.03
+344.80%
257.65
-32.74%
383.09
Net Issuance Payments Of Debt
100.45
-89.65%
970.87
+4897.78%
19.43
-95.83%
466.00
Issuance Of Debt
971.05
-64.33%
2,722.42
+479.43%
469.85
-45.41%
860.60
Repayment Of Debt
-870.60
+50.30%
-1,751.55
-288.87%
-450.42
-14.15%
-394.60
Long Term Debt Issuance
611.83
-70.41%
2,067.72
+1464.67%
132.15
-79.45%
643.13
Long Term Debt Payments
-433.54
+68.84%
-1,391.22
-18299.93%
-7.56
+96.16%
-197.00
Net Long Term Debt Issuance
178.29
-73.65%
676.50
+442.98%
124.59
-72.07%
446.13
Short Term Debt Issuance
359.23
-45.13%
654.70
+93.87%
337.69
+55.28%
217.47
Short Term Debt Payments
-437.06
-21.29%
-360.33
+18.64%
-442.86
-124.12%
-197.60
Net Short Term Debt Issuance
-77.83
-126.44%
294.37
+379.92%
-105.16
-629.20%
19.87
Net Common Stock Issuance
—
510.52
0.00
0.00
Net Other Financing Charges
96.78
-44.75%
175.16
-26.47%
238.23
+387.31%
-82.92
Changes In Cash
49.37
-68.11%
154.84
+332.84%
-66.50
-239.70%
47.60
Effect Of Exchange Rate Changes
12.35
+249.28%
-8.28
-241.24%
-2.42
+94.86%
-47.17
Beginning Cash Position
236.98
+162.09%
90.42
-43.26%
159.34
+0.27%
158.91
End Cash Position
298.71
+26.05%
236.98
+162.09%
90.42
-43.26%
159.34
Free Cash Flow
-293.16
+63.74%
-808.58
-103.99%
-396.38
+34.10%
-601.50
Interest Paid Supplemental Data
182.99
-2.82%
188.30
+23.59%
152.36
+4.89%
145.26
Income Tax Paid Supplemental Data
0.11
-26.35%
0.15
-83.52%
0.90
-70.20%
3.01
Change In Income Tax Payable
5.95
+5787.13%
0.10
-85.67%
0.70
-13.81%
0.82
Change In Tax Payable
5.95
+5787.13%
0.10
-85.67%
0.70
-13.81%
0.82
Common Stock Issuance
—
510.52
0.00
0.00
Dividends Received CFI
3.19
-68.12%
10.00
-16.82%
12.02
+135.68%
5.10
Earnings Losses From Equity Investments
-50.52
-301.70%
-12.58
+78.42%
-58.29
-230.29%
-17.65
Issuance Of Capital Stock
—
510.52
0.00
0.00
Sale Of Business
0.00
-100.00%
9.06
-84.91%
60.00
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category